Capricor Therapeutics (CAPR) Shares Issued (2016 - 2025)
Historic Shares Issued for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $6950.0.
- Capricor Therapeutics' Shares Issued fell 9999.07% to $6950.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 million, marking a year-over-year increase of 178.54%. This contributed to the annual value of $152.3 million for FY2024, which is 49698.02% up from last year.
- According to the latest figures from Q3 2025, Capricor Therapeutics' Shares Issued is $6950.0, which was down 9999.07% from $19580.0 recorded in Q2 2025.
- Capricor Therapeutics' Shares Issued's 5-year high stood at $80.8 million during Q4 2024, with a 5-year trough of -$1543.0 in Q4 2021.
- Over the past 5 years, Capricor Therapeutics' median Shares Issued value was $1.8 million (recorded in 2022), while the average stood at $11.6 million.
- As far as peak fluctuations go, Capricor Therapeutics' Shares Issued crashed by 10010.75% in 2021, and later surged by 80372929.36% in 2022.
- Capricor Therapeutics' Shares Issued (Quarter) stood at -$1543.0 in 2021, then surged by 803729.29% to $12.4 million in 2022, then tumbled by 98.22% to $221081.0 in 2023, then skyrocketed by 36465.61% to $80.8 million in 2024, then plummeted by 99.99% to $6950.0 in 2025.
- Its Shares Issued was $6950.0 in Q3 2025, compared to $19580.0 in Q2 2025 and $50354.0 in Q1 2025.